Chronic Respiratory Disease Questionnaire (2024)

Learn more

Register Now

Area of Assessment

Quality of Life

Assessment Type

Patient Reported Outcomes

Administration Mode

Paper & Pencil

Cost

Not Free

Cost Description

License agreement is required. Information can be found on the American Thoracic Society Website.

• Consists of 20 items across four dimensions: dyspnea, fatigue, emotional function, and mastery.
• Originally was administered bya clinician, but has since been modified to a self-report measure.
• The dyspnea portion is individualized to each person: the person is asked to select the 5 activities associated with breathlessness that they perform frequently and are most important to them.
• Dyspnea items may be selected from a list of 26 suggested items or may be written in by the patients.
• Items in each section are scored from 1 (most severe) to 7 (no impairment).

Number of Items

20

• Copy of questionnaire
• pen/pencil

Required Training

No Training

ICF Domain

Body Function

Measurement Domain

General Health

COPD:(Redelmeier et al, 1996;n= 112 patients with COPD who were participating ina supervised respiratory rehabilitation and in stable health; mean age = 67 (10) years)

• MCID = a change of 0.5 per item

COPD: (Rutten-van Molken et al, 1999; n = 144 patients with COPD, broken into three treatment groups; n = 47 taking Salmeterol and Ipatropium Bromide, 47 taking Salmeterol and placebo, and 50 taking placebo and placebo; mean age by treatment group = 63(7.1), 65.4(5.8) and 63.2(7.4) years)

Baseline characteristics of the study population

COPD:(Wijkstra et al, 1994;n= 43 patient with severe airflow obstruction; mean age = 64(5) years for the rehab group and 62(5) for the control group)

• Excellenttest re-test reliability (rho = 0.90)

COPD: (Williams, 2001;n= 52 patients with COPD; mean age = 66.5(7.9) years)

• Excellenttest re-test reliability for all four dimensions(ICC = 0.83-0.95)

COPD:(Wijkstra et al, 1994)

• Adequateto excellentinternal consistency for all four dimensions(Cronbach's alpha = 0.71-0.88)

COPD:(Harper et al, 1997;n =76 men and 80 women with COPD attending routine outpatient clinic; mean age = 67(10.4) years for men and 62(10.3) years for women)

• Excellentinternal consistency for all four dimensions(Cronbach's alpha = 0.8-0.85)

COPD:(Rutten-van Molken et al, 1999)

• Excellentinternal consistency (Chronbach's alpha = 0.84)

COPD:(Hajiro et al, 1998;n= 143 men with COPD; mean age = 68.8(6.9) years)

• Excellentinternal consistency (Chronbach's alpha = 0.90)

COPD:(Hajiro et al, 1998)

COPD:(Wijkstra et al, 1994)

• Poor correlations between CRQ and lung function (PFTs)
• Poor correlations between CRQ and exercise capacity (6MW, CPET)

Chronic airflow limitation:(Guyatt et al, 1987;n= 100 patients with chronic airflow limitation)

• Responsiveness was tested by administering the questionnaire to 13 patients before and after their drug treatment and to another 28 before and after participation in a respiratory rehabilitation program

• There were statistically significant improvements in all four dimensions

Quality of life:(Jaeschke et al, 1989;a literature review ofquality of life instruments)

• A change in the score of 0.5 on the 7 point scale reflects a clinically significant small change

• A change of 1.0 reflects a moderate change

• A difference of 1.5 represents a large change

Quality of life:(Jaeschke, 1989)

• MCID = a change of 0.5 per item